Cactus Cl A saw a positive improvement to its Relative Strength (RS) Rating on Monday, rising from 75 to 83.
IBD's proprietary RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that shows how a stock's price performance over the trailing 52 weeks matches up against the rest of the market.
Decades of market research shows that the market's biggest winners tend to have an RS Rating of above 80 in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Cactus Cl A is not currently showing a potential buy point. See if the stock goes on to build a chart pattern that could kick off a new price move.
The company saw both earnings and sales growth rise last quarter. Earnings-per-share increased from -4% to -1%. Revenue rose from -5% to 2%.
The company holds the No. 6 rank among its peers in the Oil & Gas-Machinery/Equipment industry group. Archrock, Baker Hughes and TechnipFMC are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
